Califf Talks to Regulatory Affairs Group at NCBiotech Event
Ticket sales close Wednesday, May 10, for a May 17 event featuring a talk by the immediate past U.S. FDA commissioner, Robert Califf, M.D., MACC.
Califf, now the Donald F. Fortin, M.D. professor of cardiology at the Duke University School of Medicine, will address the spring symposium of the North Carolina Regulatory Affairs Forum, one of the 20 exchange groups supported by the North Carolina Biotechnology Center.
It provides an information exchange eight or 10 times a year on regulatory affairs involving research, development or the manufacture of drugs, biologics or medical devices.
The upcoming meeting, at the Biotechnology Center, starts with a 5:30 p.m. networking session followed by Califf’s talk at 7. Admission is $20 for members, students and unemployed job seekers and
$45 for non-members.
Califf was the commissioner of food and drugs in 2016-2017 and deputy commissioner for medical products and tobacco from February 2015 until his appointment as commissioner in February 2016.
Before joining the FDA, Califf was a professor of medicine and vice chancellor for clinical and translational research at Duke. He also served as director of the Duke Translational Medicine Institute and founding director of the Duke Clinical Research Institute.
A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, healthcare quality, and clinical research, Califf has led many landmark clinical trials. He is one of the most frequently cited authors in biomedical science, with more than 1,200 publications in the peer-reviewed literature.
Califf was made a member of the National Academy of Medicine (formerly known as the Institute of Medicine (IOM)) in 2016, one of the highest honors in the fields of health and medicine. He has served as a member of the FDA Cardiorenal Advisory Panel and FDA Science Board's Subcommittee on Science and Technology.
He has also served on the board of scientific counselors for the National Library of Medicine, as well as on advisory committees for the National Cancer Institute, the National Heart, Lung, and Blood Institute, the National Institute of Environmental Health Sciences, and the Council of the National Institute on Aging.